ArticleFrontiers in oncology2022

Systematical analysis of ferroptosis regulators and identification of GCLM as a tumor promotor and immunological biomarker in bladder cancer.

Song Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.